Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Open Access
- 1 April 2002
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 22 (7), 2718-2729
- https://doi.org/10.1523/jneurosci.22-07-02718.2002
Abstract
Dysfunction of the dorsal prefrontal cortex (PFC) in schizophrenia may be associated with alterations in the regulation of brain metabolism. To determine whether abnormal expression of genes encoding proteins involved in cellular metabolism contributes to this dysfunction, we used cDNA microarrays to perform gene expression profiling of all major metabolic pathways in postmortem samples of PFC area 9 from 10 subjects with schizophrenia and 10 matched control subjects. Genes comprising 71 metabolic pathways were assessed in each pair, and only five pathways showed consistent changes (decreases) in subjects with schizophrenia. Reductions in expression were identified for genes involved in the regulation of ornithine and polyamine metabolism, the mitochondrial malate shuttle system, the transcarboxylic acid cycle, aspartate and alanine metabolism, and ubiquitin metabolism. Interestingly, although most of the metabolic genes that were consistently decreased across subjects with schizophrenia were not similarly decreased in haloperidol-treated monkeys, the transcript encoding the cytosolic form of malate dehydrogenase displayed prominent drug-associated increases in expression compared with untreated animals. These molecular analyses implicate a highly specific pattern of metabolic alterations in the PFC of subjects with schizophrenia and raise the possibility that antipsychotic medications may exert a therapeutic effect, in part, by normalizing some of these changes.Keywords
This publication has 60 references indexed in Scilit:
- Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophreniaMolecular Psychiatry, 2001
- Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic SchizophrenicsNeuropsychopharmacology, 1999
- Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’Molecular Psychiatry, 1999
- Modulation and Block of Ion Channels: A New Biology of PolyaminesCellular Signalling, 1997
- Transgenic animals as models in the study of the neurobiological role of polyaminesProgress in Neurobiology, 1995
- Aspects of Oxidative Metabolism in SchizophreniaThe British Journal of Psychiatry, 1995
- A study of altered gene expression in frontal cortex from schizophrenic patients using differential screeningSchizophrenia Research, 1995
- Role of polyamines in the membrane pathology of schizophrenia a study using fibroblasts from schizophrenic patients and normal controlsSchizophrenia Research, 1994
- Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measuresSchizophrenia Research, 1994
- Modulation of the NMDA receptor by polyaminesLife Sciences, 1991